JAMA Otolaryngology–Head & Neck Surgery : Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab
JAMA Network
00:00
Exploring Transformations in Head and Neck Cancer Treatment
This chapter explores the shift towards neoadjuvant immunotherapy in head and neck cancer care. It emphasizes the balance between improving patient quality of life and survival outcomes, while discussing the careful patient selection necessary for effective treatment.
Transcript
Play full episode
